Autonomic Pharmacology Flashcards
Muscarinic ACh Receptors
Main antigen is acetylcholine
Parasympathetic post ganglionic neurons
M1, M3, M5: IP3 pathway > increase Ca2+ > SM contraction
M2, M4: inhibit adenyly cyclase and reduce cAMP
Adrenergic Receptors
Receptor antigen is norepinephrine or epinephrine (adrenaline: synthesized in adrenal medulla via enzyme phenethanolamine N-methyltransferase)
Sympathetic nervous system
Nicotinic ACh Receptors
Preganglionic neurons of parasympathetics, somatic muscle neuromuscular junction
Activation via acetylcholine (release inhibited by botulinum toxin (Botox)
Muscarinic activation
- Slows cardiovascular function
- Increases secretions
- increases intestinal activity
Cotinine
Main metabolite of nicotine in body
Used for laboratory testing to see if someone smokes
Varenicline
partial agonist of a4B2 neuronal nicotinic receptors
Used: treat nicotine dependence and reduces the cravings
Mivacurium
nicotinic receptor antagonist (competitive)
Use: neuromuscular blocker = paralyzer
Used in surgeries
Pancuronium
nicotinic receptor antagonist (competitive)
Use: neuromuscular blocker = paralyzer
Used in surgeries
Vecuronium
nicotinic receptor antagonist (competitive)
Use: neuromuscular blocker = paralyzer
Used in surgeries
Three common organophosphate AchE inhibitors in industry
pesticides, parathion, chloropyrifos, malathion (insecticide) and nerve gas (sarin, tabun, VX)
Initial binding to AChE can be reversed but after a few hours, phosphorylated enzyme ages (covalent bond formed) > irreversible
Neostigmine
AchE inhibitor
Reversal of non-depolarizing neuromuscular blockers
Use: Treatment of myasthenia gravis
SE: Poisoning > activation of both muscarinic and nicotinic receptors > fatal
Pyridostigmine
AchE inhibitor
Use: main treatment for myasthenia gravis
Donepezil (Aricept)
AChE Inhibitor
Uses: Palliative treatment of Alzheimer’s disease
Galantamine (Razadyne)
AChE Inhibitor
Uses: Palliative treatment of Alzheimer’s disease
Rivastigmine (Exelon)
AChE Inhibitor
Uses: Palliative treatment of Alzheimer’s disease
Pralidoxime (2-PAM)
Prevents irreversible binding of organophosphate AChE inhibitors to AChE if given prior to a few hours
Toxicity effects of acetylcholinesterase inhibitors
DUMBELSS: diarrhea, urination, miosis (contraction of sphincter in eye), bronchoconstrictoin, excitation of muscle (most life threatening) and CNS, lacrimation, salivation, sweating
-Overload of skeletal nicotinin Ach receptors > muscle paralysis > death
Atropine (belladonna)
Muscarinic antagonist: tertiary amine that can cross BBB (can cause sedation, behavioral excitation and hallucinations)
Uses: Dilate pupils, treat severe bradycardia
Can be given to help relieve AChE inhibitor poisoning to block muscarinic effects (diarrhea)
Bethanechol
muscarinic agonist (agonist for muscarinic receptors not often used) Use: treatment of urinary retention
Betanechol, carbachol, pilocarpine
Muscarinic agonist
Contract pupillary constrictor > allow aqueous humor to drain out of eye
Uses: Acute glaucoma attack (outflow of aqueous humor into canal of Schlemm is blocked)
SE of anti-muscarinic drugs
Decreased secretions (dry mouth), mydriasis (dilated pupil), cycloplegia (decreased accommodation), hyperthermia, tachycardia, sedation (BBB), bronchodilation, urinary retention, constipatoin, behavior excitation and hallucinations (BBB)
Scopolamine
Muscarinic antagonist (can cross BBB) Use: motion sickness due to sedative and amnesiac effects